Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Acquisitions (2016 - 2025)

Surgery Partners' Acquisitions history spans 12 years, with the latest figure at $109.5 million for Q4 2025.

  • For Q4 2025, Acquisitions rose 25.0% year-over-year to $109.5 million; the TTM value through Dec 2025 reached $162.1 million, down 57.21%, while the annual FY2025 figure was $162.1 million, 57.21% down from the prior year.
  • Acquisitions for Q4 2025 was $109.5 million at Surgery Partners, up from $4.6 million in the prior quarter.
  • Across five years, Acquisitions topped out at $210.0 million in Q2 2024 and bottomed at $2.1 million in Q1 2021.
  • The 5-year median for Acquisitions is $35.9 million (2023), against an average of $52.7 million.
  • The largest annual shift saw Acquisitions surged 7400.0% in 2024 before it tumbled 98.1% in 2025.
  • A 5-year view of Acquisitions shows it stood at $184.8 million in 2021, then tumbled by 65.48% to $63.8 million in 2022, then plummeted by 51.1% to $31.2 million in 2023, then skyrocketed by 180.77% to $87.6 million in 2024, then increased by 25.0% to $109.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Acquisitions are $109.5 million (Q4 2025), $4.6 million (Q3 2025), and $4.0 million (Q2 2025).